RxDoctor Payments Data

Clarence Alexander, MD

Family Medicine · Florence, SCNPI 1154394153

Payments from drug & device makers

$13,661in general payments, 2019–2025

Across 941 payments — averaging $14.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Boehringer Ingelheim$2K
  • AbbVie$1K
  • AstraZeneca$982
  • GSK$954
  • Pfizer$782
  • plus $6K from 50 others

What the payments were for

  • Food & beverage$13,647100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk159$2,008
Boehringer Ingelheim85$1,528
AbbVie(2 entities)114$1,430
AstraZeneca62$982
GSK65$954
Pfizer62$782
Lilly USA, LLC53$628
Amgen(2 entities)31$480
Merck40$452
Novartis23$367
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC23$357
Johnson & Johnson29$355
Takeda Pharmaceuticals U.S.A., Inc.15$231
Abbott11$201
Sumitomo Pharma America, Inc.8$200
Esperion Therapeutics, Inc.11$195
Amarin Pharma, Inc.13$192
Ironwood Pharmaceuticals, Inc12$190
Bayer10$160
E.r. Squibb & Sons, L.L.C.10$146
Corcept Therapeutics6$137
Exact Sciences8$137
Antares Pharma, Inc.7$132
Astellas Pharma US Inc7$125
Boston Scientific6$103
Dynavax Technologies Corporation5$93
Sunovion Pharmaceuticals Inc.4$86
Sanofi Pasteur Inc.5$81
Dexcom, Inc.4$73
Biohaven Pharmaceuticals, Inc.4$64
Axsome Therapeutics, Inc.4$62
Sanofi-aventis U.S. LLC3$59
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$56
Teva Pharmaceuticals USA, Inc.4$54
Nevro Corp.3$52
Insulet Corporation2$52
Biohaven Pharmaceutical Holding Company Ltd.3$48
Eisai Inc.3$48
Nestle Healthcare Nutrition Inc.3$43
Daiichi Sankyo Inc.2$43
Mylan Specialty L.p.2$30
Kaleo, Inc.2$27
Novavax Inc1$25
Phathom Pharmaceuticals, Inc.2$22
Hologic Sales And Service, LLC1$21
Corium, LLC1$18
Xeris Pharmaceuticals, Inc.1$18
Shield Therapeutics Inc1$16
Genentech USA, Inc.1$15
Seqirus USA Inc1$14
Otsuka America Pharmaceutical, Inc.1$13
Kowa Pharmaceuticals America, Inc.1$11
Hikma Pharmaceuticals USA1$11
Upsher-smith Laboratories LLC1$11
Clarus Therapeutics Inc.1$11
Cashflow Solutions, LLC1$9

How this compares

$13,661 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$234,707
Medicare patients
488
Services billed
3,387

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin298$292,620
OzempicSemaglutide247$254,195
EliquisApixaban113$138,742
MounjaroTirzepatide80$91,597
FarxigaDapagliflozin Propanediol69$73,704
XareltoRivaroxaban55$56,057
JanuviaSitagliptin Phosphate47$55,422
Tresiba Flextouch U-100Insulin Degludec49$38,394
MyrbetriqMirabegron44$36,979
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog47$32,886
OxycontinOxycodone Hcl30$25,511
EntrestoSacubitril/Valsartan18$25,362
NexletolBempedoic Acid28$23,736
Tresiba Flextouch U-200Insulin Degludec16$20,285
Repatha SureclickEvolocumab23$18,672

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat$1,528$299,954309 claims
Novo NordiskOzempic, Rybelsus$2,008$267,324260 claims
PfizerEliquis, Premarin$782$145,332127 claims
Lilly USA, LLCMounjaro$628$91,59780 claims
AstraZenecaFarxiga$982$73,70469 claims
Johnson & JohnsonXarelto$355$56,05755 claims
MerckJanuvia$452$55,42247 claims
Astellas Pharma US IncMyrbetriq$125$36,97944 claims
Esperion Therapeutics, Inc.Nexletol, Nexlizet$195$31,23639 claims
NovartisEntresto$367$25,36218 claims
GSKBreo Ellipta, Anoro Ellipta$954$17,41927 claims
Sumitomo Pharma America, Inc.Gemtesa$200$7,76912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →